Prime Health Melatonin 10mg Sublingual Tablets
Natural health product licensed in Canada
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| N-[2-(5-méthoxy-1H-indol-3-yl)éthyl]acétamide Source : Mélatonine | 10 mg |
Non-medicinal ingredients
Sucralose, Acide stéarique, Croscarmellose de sodium, Dioxyde de silicium, Cellulose microcristalline, D-Mannitol, Sorbitol, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Comprimé | 1 day |
Uses authorised in Canada
Helps increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule, e.g. shift-work and jet lag.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If symptoms persist continuously for more than 4 weeks (chronic insomnia), consult your health care practitioner. If you have one of the following conditions, consult a health care practitioner prior to use: asthma, cardiovascular disease, chronic kidney disease, depression, diabetes or hypoglycaemia, hormonal disorder, immune system disease, liver disease, migraine, or seizure disorders. If you are taking one of the following medications, consult a health care practitioner prior to use: anticoagulant, anticonvulsant, blood pressure medications, immunosuppressive medications, sedative, hypnotic or psychotropic medications, or steroids. Consumption with alcohol, other medications or natural health products with sedative properties is not recommended.
- Effets indésirables connus
Rare allergic reactions have been known to occur in which case, discontinue use. Mild gastrointestinal symptoms (nausea, vomiting, or cramping) have been known to occur in which case, discontinue use.
- Contre-indications
If you are pregnant or breastfeeding, do not use this product.
Product record
- Other names
- CanaMed Melatonin 10mg Sublingual Tablets, Canda Melatonin 10mg Sublingual Tablets, Maple Health Melatonin 10mg Sublingual Tablets, Maple Leaf Melatonin 10mg Sublingual Tablets, The Perfect Life Melatonin 10mg Sublingual Tablets
- Licence holder
- Prime Health Ltd. (Canada Global Life Sciences)
- NPN or DIN-HM
- 80045914
- Status
- Active licence
- Licence date
- 30 October 2013
- Revision date
- 24 May 2022
- Form
- Comprimé
- Route of administration
- Sublinguale
- Application type
- Officinale
Source
Official Health Canada record, licence 80045914
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Prime Health Melatonin 10mg Sublingual Tablets (Prime Health Ltd. (Canada Global Life Sciences)): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80045914-prime-health-melatonin-10mg-sublingual-tablets, updated 24 May 2022.